Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant weight loss, with one in three study participants…
Citadel, BlackRock, Vanguard, Jane Street, Northern Trust, Man Group, and State Street amongst others take positions as institutional ownership surpasses…
September 06, 2025 14:30 ET | Source: BridgeBio Pharma, Inc. - 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and…
Medidata eCOA was the highest Leader recognized in the evaluation, supporting over 1M+ patients and reducing study build timeline by…
Kia’s total sales in August reached 83,007 units, up 10.4 percent year-over-yearYear to date total sales are up 8.6 percent,…
From turning waste into want, to reshaping what premium looks like — Great Galleon Ventures Limited sets a new benchmark…
Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American…
Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater reduction in the risk of heart attack, stroke…
IMG took a sample of its customers and reviewed more than 30,000 travel itineraries of members with upcoming travel plans…
Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an…